Several studies have reported that CAR-T cells incorporating 4-1BB costimulatory domains have a significant differential signature and kinetics of lymphoma elimination as compared to CAR-T cells characterized by the presence of the CD28 costimulatory domain25. Here, CD28 is linked to lymphoma.